from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3519/-

LFCtreatmentdescriptionclass of inhibitor

0.170

Amikacinug/mL Amikacintranslation

0.504

Cap5-10ug/mL Capreomycintranslation

1.032

Rox10-50 ug/mL Roxithromycintranslation

0.404

SM2-5 ug/mL Streptomycintranslation

-1.317

Tet5-10 ug/mL Tetracyclinetranslation

-0.453

Rif0.2-5ug/mL Rifampicintranscription

-0.514

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.031

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.758

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.468

CPZ10-50 ug/mL Chlorpromazinerespiration

0.878

Clofazimine10-13 ug/mL Clofaziminerespiration

0.173

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.540

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.150

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.896

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.611

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.042

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.276

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.867

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.678

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.105

KCN5-20 ug/mL Potassium cyaniderespiration

0.913

NaN30.2-2 mM Sodium aziderespiration

0.135

Nigericin50 uM Nigericinrespiration

0.270

TRC10-150 ug/mL Triclosanrespiration

1.143

TRZ10-25 ug/mL Thioridazinerespiration

-0.392

Valinomycin0.5-10 uM Valinomycinrespiration

0.344

ZnSO42 mM ZnSO4respiration

1.616

menadione6-10 ug/mL Menadionerespiration

0.624

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.157

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.014

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.092

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.099

NRP_1Non-replicating persistence stage 1dosRassociated

-0.293

Amp0.2mg/mL AmpicillincellWall

-0.038

Cephalexin20-100 ug/mL CephalexincellWall

-0.359

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.518

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.519

EMB10-20 ug/mL EthambutolcellWall

0.198

Eta12-40 ug/mL EthionamidecellWall

0.076

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.222

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.160

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.047

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.607

BZA0.12 mg/mL BenzamidearomaticAmides

-0.969

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.836

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.479

H2O24 mM hydrogen peroxideDNAdamaging

0.048

Levo10 ug/mL LevofloxacinDNAdamaging

-1.356

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.134

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.296

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.685

UVUV-irradiationDNAdamaging

0.412

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.100

Antimycin12.5-50 ug/mL Antimycin A?

0.019

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.624

PA_110-50 ug/mL Antitubercular compound PA-1?

0.542

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.388

PA8240.2-2 ug/mL PA-824?

0.417

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.244

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.399

Verapamil50 uM Verapamil?

0.734

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.669

methoxatin10-20 ug/mL Methoxatin?